| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.1 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.42 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |